Emma Walmsley | CEO |
Nick Stone | Head of Investor Relations |
Brian McNamara | CEO of GSK Consumer Healthcare |
Iain Mackay | CFO |
Hal Barron | Chief Scientific Officer |
Roger Connor | President of GSK |
David Redfern | Chief Strategy Officer |
Deborah Waterhouse | CEO of ViiV Healthcare |
Luke Miels | Chief Commercial Officer |
James Gordon | JP Morgan |
Peter Holford | Jefferies |
Mark Purcell | Morgan Stanley |
Simon Martha | Exane |
Graham Parry | Bank of America |
Seamus Fernandez | Guggenheim |
Andrew Baum | Citi |
Laura Sutcliffe | UBS |
Kerry Holford | Berenberg |
Good afternoon, everyone and welcome to the analyst call on the GSK's Third Quarter 2021 Results. I will now hand you over to Nick Stone, Head of Investor Relations, who will introduce today's session.
Thank you, Operator. And good morning and good afternoon.
As you've just said, I am Nick Stone, Head of Investor Relations at GSK.